ArticleJournal of nanobiotechnology2026

Red blood cell-derived extracellular vesicles enable cisplatin and cetuximab combined therapy against triple-negative breast cancer.

Miriam Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.